Rick Balestra in Portland, Oregon

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: Sorry, his university is not listed
Graduation Year: 2003
The Primary Medical Specialty for Rick Balestra is listed as: Pulmonary Disease
Approximate Years of Experience: 21
PAC (PECOS ID)#: 7214123785
NPI #: 1184824351
NPI Created On: 07/24/2007
NPI Last Updated Listed as: 12/01/2021
Primary Taxonomy Code: 207RP1001X
License Number:
MD169371
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Moda Health Plan, Inc.
• Providence Health Plan
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Irrigation and suction of lung airways to obtain cells using an endoscope
2. Biopsy of one lobe of lung using an endoscope
3. Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope
4. Destruction of growth or narrowing of lung airway using an endoscope
5. Examination of lung airways using an endoscope with imaging guidance and ultrasound
6. Insertion of central venous catheter for infusion, patient 5 years or older
7. Insertion of arterial catheter for blood sampling or infusion, accessed through the skin
8. Ct scan chest
9. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
10. Determination of lung volumes using gas dilution or washout
11. Measurement of lung diffusing capacity
12. New patient office or other outpatient visit, typically 45 minutes
13. Established patient office or other outpatient visit, typically 15 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Subsequent hospital inpatient care, typically 25 minutes per day
16. Subsequent hospital inpatient care, typically 35 minutes per day
17. Critical care delivery critically ill or injured patient, first 30-74 minutes
18. Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg